SEC Form 4 · Updated Daily
FULC
Insider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| GLAXOSMITHKLINE PLC | 10%+ Owner | 1,785,714 | 2019-07-22 | C |
| Sanofi | 10%+ Owner | 558,035 | 2019-07-22 | P |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2019-07-22 | GLAXOSMITHKLINE PLC | Conversion (derivative) | 12,500,000 | $0.00 | 0 |
| 2019-07-22 | GLAXOSMITHKLINE PLC | Conversion | 1,785,714 | — | 1,785,714 |
| 2019-07-22 | Sanofi | Conversion (derivative) | 3,250,000 | $0.00 | 0 |
| 2019-07-22 | Sanofi | Open-market buy | 93,750 | $16.00 | 558,035 |
| 2019-07-22 | Sanofi | Conversion | 464,285 | $0.00 | 464,285 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.